The depletion of RAD51 expression in 4T1.2 cells lead to a significant delay in primary tumor growth in vivo (p=0.0013)(Fig 2C), with sustained depletion of RAD51 at the primary site and overexpression observed in metastatic tumours (Supplementary Figure 2). The gene discussed is RAD51; the disease is neoplasm.